Trials / Completed
CompletedNCT02440633
A Phase 1,Open -Label Study to Assess the Absorption, Metabolism and Excretion of 14C-OPS-2071 Following a Single Oral Dose to Healthy Male Japanese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 35 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To obtain absorption, metabolism and excretion data for parent drug and any metabolites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 14C-OPS-2071 | Subjects will swallow Single 25 mL of suspension containing 50 mg of 14C-OPS-2071 directly. |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2015-05-12
- Last updated
- 2016-10-21
- Results posted
- 2016-08-24
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02440633. Inclusion in this directory is not an endorsement.